Northwest Biotherapeutics | NWBO - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Northwest Biotherapeutics

Northwest Biotherapeutics reported $26.62M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Agenus AGEN:US USD 13.65M 490K
AstraZeneca AZN:LN USD 31.5B 2.27B
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
CTI Biopharma CTIC:US USD 118.77M 9.69M
Eisai 4523:JP JPY 126.1B 24.02B
Northwest Biotherapeutics NWBO:US USD 26.62M 5.1M
Plus Therapeutics, Inc. CYTX:US USD 5.06M 337K
Roche Holding ROG:VX CHF 25.35B 2.4B